Use of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatment

Journal of Controlled Release

Volumn 151, Issue 3, 2011, Pages 239-245

  He, Hongyan ^a,b   Grignol, Valerie ^c   Karpa, Volodymyr ^c   Yen, Chi ^a   Laperle, Krista ^c   Zhang, Xiaoli ^c   Jones, Natalie B ^c   Liang, Margaret I ^c   Lesinski, Gregory B ^c   Ho, W S Winston ^a   Carson III, William E ^c   Lee, L James ^a  

^a Ohio State University   (United States)

^b BioLOC LLC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Biodegradable nanoporous miniature device (NMD); Interferon alpha release; Malignant melanoma; Nanoporous membrane; PCL

Indexed keywords

INTERFERON-ALPHA RELEASE; MALIGNANT MELANOMA; MINIATURE DEVICES; NANOPOROUS MEMBRANE; PCL;

ANTIBIOTICS; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; DERMATOLOGY; DRUG DELIVERY; ETHYLENE; ETHYLENE GLYCOL; EXPERIMENTS; GLYCOPROTEINS; INTERFERONS; MINIATURE INSTRUMENTS; ONCOLOGY; PHOSPHORYLATION; POLYCAPROLACTONE; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; TUMORS; VISUALIZATION;

EQUIPMENT;

ACRYLIC ACID DERIVATIVE; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; MACROGOL; POLYCAPROLACTONE; RECOMBINANT ALPHA2B INTERFERON; STAT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER THERAPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DEVICE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG STABILITY; EQUIPMENT DESIGN; FEMALE; HUMAN; HUMAN CELL; IMPLANT; MELANOMA; MOUSE; NANOFABRICATION; NANOPORE; NANOPOROUS MINIATURE DEVICE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CAPSULES; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INTERFERON ALFA-2B; MELANOMA, EXPERIMENTAL; MEMBRANES, ARTIFICIAL; MICE; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; NANOPORES; SOLUBILITY; SURFACE PROPERTIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957495866     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.02.020     Document Type: Article

References (31)

1. K.M. McMasters, V.K. Sondak, M.T. Lotze, and M.I. Ross Recent advances in melanoma staging and therapy Ann. Surg. Oncol. 6 1999 467 475 (Pubitemid 29379565)
2. F. Belardelli, M. Ferrantini, E. Proietti, and J.M. Kirkwood Interferon-alpha in tumor immunity and immunotherapy Cytokine Growth Factor Rev. 13 2002 119 134 (Pubitemid 34229387)
3. M.B. Atkins Immunotherapy and experimental approaches for metastatic melanoma Hematol. Oncol. Clin. N. Am. 12 1998 877 902 (Pubitemid 28410381)
4. T. Crosby, R. Fish, B. Coles, and M. Mason Systemic treatments for metastatic cutaneous melanoma Cochrane Database Syst. Rev. 4 2009 1 9
5. E.S. Chung, M.S. Sabel, and V.K. Sondak Current state of treatment for primary cutaneous melanoma Clin. Exp. Med. 4 2 2004 65 77 (Pubitemid 39506598)
6. S.J. Haque, and B.R. Williams Signal transduction in the interferon system Semin. Oncol. 25 1998 14 22 (Pubitemid 28093151)
7. P. von Wussow, B. Block, F. Hartmann, and H. Deicher Intralesional interferon-alpha therapy in advanced malignant melanoma Cancer 61 6 1988 1071 1074 (Pubitemid 18078593)
8. D. Ikic, S. Spaventi, I. Padovan, Z. Kusic, V. Cajkovac, D. Ivankovic, N. Dakovic, and P. Nola Local interferon therapy for melanoma patients Int. J. Dermatol. 34 12 1995 872 874
9. G.B. Lesinski, S.V. Kondadasula, T. Crespin, K. Kendra, M. Walker, and W.E. Carson Multiparametric flow cytometric analysis of interpatient variation in STAT1 phosphorylation following IFN-alpha immunotherapy reveals dose-dependent signal transduction JNCI J. Natl. Cancer Inst. 96 17 2004 1142 1331
10. R. Duncan, H. Ringsdorf, and R. Satchi-Fainaro Polymer therapeutics: polymers as drugs, drug and protein conjugates and gene delivery system: past, present, and future opportunities Adv. Polym. Sci. 192 2006 1 8
11. L.J. Lee Polymer nanoengineering for biomedical applications Ann. Biomed. Eng. 34 2006 75 88
12. R.A. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 23 2000 2475 2490
13. R. Langer Biomaterials in drug delivery and tissue engineering: one laboratory's experience Acc. Chem. Res. 33 2 2000 94 101
14. D.A. LaVan, T. McGuire, and R. Langer Small-scale systems for in vivo drug delivery Nat. Biotechnol. 21 2003 1184 1191 (Pubitemid 37186175)
15. F. Martin, R. Walczak, A. Boiarski, M. Cohen, T. West, C. Cosentino, and M. Ferrari Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics J. Control. Release 102 2005 123 133 (Pubitemid 40103555)
16. T.A. Desai, D. Hansford, and M. Ferrari Nanopore technology for biomedical applications Biomed. Microdevices 2 1999 11 40 (Pubitemid 129644453)
17. W.J. Lin, and C.H. Lu Characterization and permeation of microporous poly(ε-caprolactone) films J. Membr. Sci. 198 2002 109 118
18. K.S. Tiaw, S.H. Teoh, R. Chen, and M.H. Hong Processing methods of ultrathin poly(ε-caprolactone) films for tissue engineering applications Biomacromolecules 8 2007 807 816 (Pubitemid 46499213)
19. T. Tanaka, T. Tsuchiya, H. Takahashi, M. Taniguchi, and D.R. Lloyd Microfiltration membrane of polymer blend of poly(L-lactic acid) and poly(ε-caprolactone) Desalination 1993 2006 367 374 (Pubitemid 44141993)
20. H.I. Chiang, Y. Perrie, and A.G.A. Coombes Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone J. Control. Release 110 2006 414 421 (Pubitemid 41829567)
21. C. Yen, H. He, L.J. Lee, and W. Ho Synthesis and characterization of polycaprolactone nanoporous membranes for biomedical applications J. Membr. Sci. 343 2009 180 188
22. C. Yen, H. He, Z. Fei, X. Zhang, L.J. Lee, and W.S. Winston Ho Surface modification of nanoporous poly(caprolactone) membrane with poly(ethylene glycol) to prevent biofouling: part i. Effects of plasma power and treatment time Int. J. Polym. Mater. 59 11 2010 923 942
23. C. Yen, H. He, Z. Fei, X. Zhang, L.J. Lee, and W.S. Winston Ho Surface modification of nanoporous poly(caprolactone) membrane with poly(ethylene glycol) to prevent biofouling: part ii. Effects of graft density and chain length Int. J. Polym. Mater. 59 11 2010 943 957
24. R. Parihar, J. Dierksheide, Y. Hu, and W.E. Carson IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells J. Clin. Invest. 110 2002 983 992
25. X. Zhang, and H. He Test A biodegradable, immunoprotective, dual nanoporous capsule for cell based therapies Biomaterials 29 31 2008 4253 4259
26. E.S. Carlisle, M.R. Mariappan, K.D. Nelson, B.E. Thomes, R.B. Timmons, and A. Constantinescu Enhancing hepatocyte adhesion by pulsed plasma deposition and polyethylene glycol coupling Tissue Eng. 6 2000 45 52 (Pubitemid 30123982)
27. G.B. Lesinski, E.T. Raig, K. Guenterberg, L. Brown, M.R. Go, N.N. Shah, A. Lewis, M. Quimper, E. Hade, G. Young, A.R. Chaudhury, K.J. Ladner, D.C. Guttridge, P. Bouchard, and W.E. Carson IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis Cancer Res. 68 2008 8351 8360
28. J.M. Harris Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications 1992 Plenum Press New York
29. N. Faucheux, R. Schweiss, K. Lutzow, C. Werner, and T. Groth Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies Biomaterials 25 2004 2721 2730 (Pubitemid 38202319)
30. F.Q. Nie, Z.K. Xu, X.J. Huang, P. Ye, and J. Wu Acrylonitirle-based copolymer membranes containing reactive group: surface modification by the immobilization of poly(ethylene glycol) for improving antifouling property and biocompatibility Langmuir 19 2003 9889 9895
31. J.M. Goddard, and J.H. Hotchkiss Polymer surface modification for the attachment of bioactive compounds Prog. Polym. Sci. 32 2007 698 725 (Pubitemid 46977434)